Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
267.00 GBX | -0.22% | +2.22% | -11.76% |
Dec. 05 | Haleon says Pfizer representative steps down from board | AN |
Nov. 28 | Blue chips flat amid M&A frenzy, missing US spark | AN |
Capitalization | 6.21B 7.92B 7.49B 6.95B 11.19B 671B 12.39B 86.42B 31.95B 275B 29.74B 29.08B 1,187B | P/E ratio 2025 * |
13.7x | P/E ratio 2026 * | 11.3x |
---|---|---|---|---|---|
Enterprise value | 11.61B 14.8B 14B 12.98B 20.92B 1,253B 23.16B 162B 59.71B 515B 55.58B 54.35B 2,218B | EV / Sales 2025 * |
0.35x | EV / Sales 2026 * | 0.34x |
Free-Float |
94.63% | Yield 2025 * |
5.06% | Yield 2026 * | 5.4% |
Last Transcript: J Sainsbury plc
1 day | -0.22% | ||
1 week | +2.22% | ||
Current month | +2.22% | ||
1 month | +0.38% | ||
3 months | -10.16% | ||
6 months | -2.55% | ||
Current year | -11.76% |
Director | Title | Age | Since |
---|---|---|---|
Simon Roberts
CEO | Chief Executive Officer | 53 | 2020-05-31 |
Blathnaid Bergin
DFI | Director of Finance/CFO | 49 | 2023-03-04 |
Clodagh Moriarty
CTO | Chief Tech/Sci/R&D Officer | - | 2023-02-28 |
Manager | Title | Age | Since |
---|---|---|---|
Brian Cassin
BRD | Director/Board Member | 57 | 2016-03-31 |
Jo Harlow
BRD | Director/Board Member | 62 | 2017-09-10 |
Simon Roberts
BRD | Director/Board Member | 53 | 2020-05-31 |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.22% | +2.22% | -7.68% | -4.03% | 7.94B | ||
-2.15% | -1.72% | +33.96% | +63.55% | 45.5B | ||
-1.68% | +2.02% | -16.99% | +20.71% | 30.44B | ||
-1.51% | +2.39% | -5.79% | -20.70% | 29.68B | ||
+2.81% | +3.98% | +11.11% | -2.56% | 18.83B | ||
-1.14% | +2.54% | +23.78% | +9.51% | 16.53B | ||
+0.52% | +0.31% | +53.24% | +115.70% | 15.59B | ||
-1.23% | +0.38% | -21.76% | -4.65% | 12.41B | ||
+0.15% | -.--% | -.--% | +0.37% | 11.82B | ||
-1.04% | +5.35% | -12.51% | +21.45% | 10.01B | ||
Average | -0.55% | +1.78% | +5.74% | +19.94% | 19.88B | |
Weighted average by Cap. | -0.89% | +1.60% | +9.22% | +24.90% |
2025 * | 2026 * | |
---|---|---|
Net sales | 33.5B 42.7B 40.41B 37.46B 60.37B 3,616B 66.83B 466B 172B 1,486B 160B 157B 6,402B | 34.26B 43.67B 41.33B 38.31B 61.75B 3,699B 68.35B 477B 176B 1,520B 164B 160B 6,548B |
Net income | 465M 593M 561M 520M 839M 50.23B 928M 6.47B 2.39B 20.64B 2.23B 2.18B 88.93B | 555M 707M 669M 620M 999M 59.86B 1.11B 7.72B 2.85B 24.6B 2.66B 2.6B 106B |
Net Debt | 5.4B 6.88B 6.51B 6.03B 9.73B 583B 10.77B 75.08B 27.76B 239B 25.84B 25.27B 1,031B | 5.47B 6.97B 6.59B 6.11B 9.85B 590B 10.91B 76.06B 28.12B 242B 26.18B 25.59B 1,045B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-06 | 267.00 p | -0.22% | 7,004,175 |
24-12-05 | 267.60 p | +1.52% | 5,339,077 |
24-12-04 | 263.60 p | +0.69% | 5,872,389 |
24-12-03 | 261.80 p | +0.85% | 5,801,765 |
24-12-02 | 259.60 p | -0.61% | 4,717,653 |
Delayed Quote London S.E., December 06, 2024 at 11:35 am EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- SBRY Stock